Literature DB >> 11787188

Population-based incidence of mammary tumours in some dog breeds.

L Moe1.   

Abstract

Data from two population-based studies in four Norwegian counties were used to calculate the crude incidence of mammary tumours, and the age- and breed-specific incidence of mammary tumours in female dogs of three different breeds. The largest study comprised 14401 histologically verified tumour cases from four counties covered by the Norwegian Canine Cancer Register. The registry covers about 25% of the total Norwegian dog population. The second study was a census in Norway that was sent to all owners of the following breeds: boxers, bichon frisé and Bernese mountain dogs, to estimate the age distribution of the female dog population at risk of developing mammary tumours. The crude incidence of malignant mammary tumours in female dogs of any breed was 53.3%. The highest relative risk ratio of mammary tumours was found in boxers, cocker spaniels, English springer spaniels and dachshunds. The mean age of histologically diagnosed mammary tumours was 7.9 years in boxers and 7.8 years in springer spaniels, compared with 8.8 years in all other breeds. In the four Norwegian counties from 1992 to 1997, the population-based incidence rates (for all ages) of malignant mammary tumours per 1000 female dogs per year were 35.47 in boxers, 3.87 in Bernese mountain dogs and 17.69 in bichon frisé. Mammary cancer is the most common tumour in female dogs in Norway, and represents a population of almost entirely reproductively intact females. The age-specific incidence rates for mammary cancer vary considerably among the three breeds that were studied in detail.

Entities:  

Mesh:

Year:  2001        PMID: 11787188

Source DB:  PubMed          Journal:  J Reprod Fertil Suppl        ISSN: 0449-3087


  43 in total

1.  Circulating level of heat shock protein 27 is elevated in dogs with mammary tumors.

Authors:  Rancy Birdi; B V Sunil Kumar; Kuldip Gupta; Neeraj Kashyap; Ashwani Kumar
Journal:  3 Biotech       Date:  2019-05-22       Impact factor: 2.406

2.  Genetic variations of BRCA1 and BRCA2 genes in dogs with mammary tumours.

Authors:  S O Enginler; I Akış; T S F Toydemir; K Oztabak; D Haktanir; M C Gündüz; I Kırşan; I Fırat
Journal:  Vet Res Commun       Date:  2013-10-13       Impact factor: 2.459

3.  5-Fluorouracil may enrich cancer stem cells in canine mammary tumor cells in vitro.

Authors:  Bin Zhou; Yipeng Jin; Di Zhang; Degui Lin
Journal:  Oncol Lett       Date:  2018-03-15       Impact factor: 2.967

Review 4.  Beyond tradition and convention: benefits of non-traditional model organisms in cancer research.

Authors:  Rebecca M Harman; Sanjna P Das; Arianna P Bartlett; Gat Rauner; Leanne R Donahue; Gerlinde R Van de Walle
Journal:  Cancer Metastasis Rev       Date:  2020-10-28       Impact factor: 9.264

5.  ErbB2 copy number gain is associated with adverse outcome in canine mammary carcinoma.

Authors:  Kosei Sakai; James Ken Chambers; Kazuyuki Uchida; Takayuki Nakagawa; Ryohei Nishimura; Tomohiro Yonezawa; Shingo Maeda
Journal:  J Vet Med Sci       Date:  2021-01-19       Impact factor: 1.267

6.  Establishment of a PCR analysis method for canine BRCA2.

Authors:  Yasunaga Yoshikawa; Masami Morimatsu; Kazuhiko Ochiai; Kento Okuda; Takahiro Taoda; Seishiro Chikazawa; Asako Shimamura; Toshinori Omi; Makoto Bonkobara; Koichi Orino; Kiyotaka Watanabe
Journal:  BMC Res Notes       Date:  2012-04-03

7.  Evaluating optical coherence tomography for surgical margin assessment of canine mammary tumours.

Authors:  Carolina Fabelo; Laura E Selmic; Pin-Cheh Huang; Jonathan P Samuelson; Jennifer K Reagan; Alexandra Kalamaras; Vincent Wavreille; Guillermo L Monroy; Marina Marjanovic; Stephen A Boppart
Journal:  Vet Comp Oncol       Date:  2020-07-26       Impact factor: 2.613

8.  Fucoxanthin Exerts Anti-Tumor Activity on Canine Mammary Tumor Cells via Tumor Cell Apoptosis Induction and Angiogenesis Inhibition.

Authors:  Hyuk Jang; Jawun Choi; Jeong-Ki Park; Gayeon Won; Jae-Won Seol
Journal:  Animals (Basel)       Date:  2021-05-23       Impact factor: 2.752

9.  Effects of the missense mutations in canine BRCA2 on BRC repeat 3 functions and comparative analyses between canine and human BRC repeat 3.

Authors:  Yasunaga Yoshikawa; Kazuhiko Ochiai; Masami Morimatsu; Yu Suzuki; Seiichi Wada; Takahiro Taoda; Satomi Iwai; Seishiro Chikazawa; Koichi Orino; Kiyotaka Watanabe
Journal:  PLoS One       Date:  2012-10-12       Impact factor: 3.240

10.  Breed-predispositions to cancer in pedigree dogs.

Authors:  Jane M Dobson
Journal:  ISRN Vet Sci       Date:  2013-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.